- Home
- PDX vs SPRY Comparison
PDX vs SPRY Comparison
Compare PDX & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDX
- SPRY
- Stock Information
- Founded
- PDX 2019
- SPRY 2015
- Country
- PDX NY
- SPRY United States
- Employees
- PDX N/A
- SPRY N/A
- Industry
- PDX Finance/Investors Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- PDX Finance
- SPRY Health Care
- Exchange
- PDX Nasdaq
- SPRY Nasdaq
- Market Cap
- PDX 1.1B
- SPRY 1.2B
- IPO Year
- PDX N/A
- SPRY N/A
- Fundamental
- Price
- PDX $21.80
- SPRY $13.44
- Analyst Decision
- PDX
- SPRY Strong Buy
- Analyst Count
- PDX 0
- SPRY 4
- Target Price
- PDX N/A
- SPRY $28.75
- AVG Volume (30 Days)
- PDX N/A
- SPRY 1.2M
- Earning Date
- PDX 01-01-0001
- SPRY 05-14-2025
- Dividend Yield
- PDX 4.95%
- SPRY N/A
- EPS Growth
- PDX N/A
- SPRY N/A
- EPS
- PDX N/A
- SPRY 0.08
- Revenue
- PDX N/A
- SPRY $89,149,000.00
- Revenue This Year
- PDX N/A
- SPRY $1.49
- Revenue Next Year
- PDX N/A
- SPRY $141.68
- P/E Ratio
- PDX N/A
- SPRY $168.31
- Revenue Growth
- PDX N/A
- SPRY 297063.34
- 52 Week Low
- PDX $13.52
- SPRY $7.55
- 52 Week High
- PDX $21.05
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- PDX 46.71
- SPRY 46.69
- Support Level
- PDX $21.85
- SPRY $13.06
- Resistance Level
- PDX $22.85
- SPRY $15.06
- Average True Range (ATR)
- PDX 0.50
- SPRY 0.67
- MACD
- PDX 0.16
- SPRY -0.18
- Stochastic Oscillator
- PDX 47.25
- SPRY 15.97
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.